The V-ATPase A2 protein is a subunit of the vacuolar-type H+-ATPase (V-ATPase) enzyme complex, which plays a critical role in acidifying a variety of intracellular compartments in eukaryotic cells. This acidification is essential for numerous cellular processes, including protein sorting, zymogen activation, and the uptake of nutrients. V-ATPases are also involved in the extracellular acidification of certain tissues, a process important for bone resorption and the activation of proteases in various physiological contexts. The A2 subunit of V-ATPase is particularly significant as it is involved in the assembly and functional regulation of the V-ATPase complex, influencing its ability to transport protons across membranes and thereby modulate the pH of cellular compartments. The activity of V-ATPase A2 and the overall V-ATPase complex is crucial for maintaining cellular homeostasis, underpinning the vitality of cellular processes dependent on intracellular pH gradients.
The activation of V-ATPase A2, and consequently the V-ATPase complex, involves several regulatory mechanisms that respond to the cellular and environmental cues dictating the need for compartmental acidification. One primary mode of activation is through the reversible assembly of the V-ATPase holoenzyme complex, where the V1 domain (responsible for ATP hydrolysis) and the V0 domain (responsible for proton translocation) come together. This assembly can be influenced by cellular energy levels, pH, and the presence of specific ions or lipids that can modulate the activity of the V-ATPase complex. Additionally, post-translational modifications of the A2 subunit or other components of the V-ATPase, such as phosphorylation, can alter the enzyme's activity, enhancing its ability to respond to the dynamic needs of the cell. Regulatory proteins may also interact with the V-ATPase complex, modulating its activity in response to specific signaling pathways. These mechanisms ensure that V-ATPase activity is finely tuned according to cellular requirements, highlighting the complex regulation of intracellular pH homeostasis and its importance in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can act as a cofactor for many enzymes and may indirectly increase the activity of V-ATPase A2 by stabilizing its structure or enhancing its binding to ATP. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
While known as an inhibitor of Na+/H+ exchangers, at specific concentrations, it could indirectly enhance the proton pump activity of V-ATPase A2 by modulating intracellular ion homeostasis. | ||||||
Escin | 6805-41-0 | sc-221596 sc-221596A sc-221596B | 1 g 5 g 10 g | $68.00 $238.00 $286.00 | 5 | |
This saponin has been shown to inhibit vacuolar ATPase activity; however, in a controlled manner, it might be used to fine-tune the activity of V-ATPase A2. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
As the primary energy source for ATP synthesis, glucose availability can indirectly increase V-ATPase A2 activity by ensuring adequate ATP levels for its operation. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
An inhibitor of F0F1-ATP synthase that can increase the proton gradient across membranes, potentially leading to a compensatory upregulation of V-ATPase A2 activity. | ||||||
N-Ethylmaleimide | 128-53-0 | sc-202719A sc-202719 sc-202719B sc-202719C sc-202719D | 1 g 5 g 25 g 100 g 250 g | $22.00 $69.00 $214.00 $796.00 $1918.00 | 19 | |
An alkylating agent that can modify cysteine residues on proteins; at specific concentrations, it could potentially enhance V-ATPase A2 activity by affecting its assembly or disassembly dynamics. | ||||||
Sodium metavanadate | 13718-26-8 | sc-251034 sc-251034A | 5 g 25 g | $32.00 $84.00 | 3 | |
Acts as a phosphate analog and inhibitor of many ATPases; at low levels, it could be used to transiently affect V-ATPase A2 activity by modulating its phosphorylation state. | ||||||